Ontario recommends Pfizer vaccine in males age 18-24 to reduce risk of rare heart inflammation

Ontario recommends Pfizer COVID-19 vaccine for males age 18-24 after findings show slightly increased risk of myocarditis and pericarditis from Moderna vaccine in about one in 5,000 males

Source : The Globe And Mail